Every 8-K that NeueHealth Inc (NEUE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow NEUE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NEUE filings page.
NeueHealth, Inc. entered into a merger under which NH Holdings 2025, Inc. (Parent) and its Merger Sub completed a merger on October 2, 2025, making the company a wholly owned subsidiary of Parent. Each outstanding share of common stock was converted into the right to receive $7.33 per share in cash, subject to withholding, while shares held by certain rollover holders were contributed to an Ultimate Parent in exchange for limited partnership interests. Options with exercise prices below $7.33 were cashed out for the spread; options with exercise prices at or above $7.33 were canceled without consideration. Service-based RSUs were assumed and converted into Parent RSUs; performance-based RSUs were canceled. The company requested NYSE suspension and delisting and submission of Form 25 to deregister its common stock.
NeueHealth, Inc. reported that the outside deadline to complete its previously announced merger has been extended. Under the existing Merger Agreement with NH Holdings 2025, Inc. and NH Holdings Acquisition 2025, Inc., the "Outside Date" has been moved to December 23, 2025, following written notice from the merger parent entity on September 18, 2025. This change gives the parties more time under the current agreement framework to work toward closing the transaction.